Published by Josh White on 30th January 2024
(Sharecast News) - Hutchmed China announced the approval of its drug 'Elunate', or fruquintinib, by the Pharmacy and Poisons Board of Hong Kong on Tuesday, for the treatment of adult patients with previously treated metastatic colorectal cancer (CRC).
URL: http://www.digitallook.com/dl/news/story/34057492/...